117 related articles for article (PubMed ID: 33684874)
1. Preparation and characterization of cyclic citrullinated peptide-immobilized latex beads for measurement of anti-citrillinated protein antibody through latex particle-enhanced turbidimetric immunoassay.
Deng X; Zeng M; Wang X; Liu J; Ma Y; Wang X; Xu L
J Chromatogr A; 2021 Apr; 1642():462000. PubMed ID: 33684874
[TBL] [Abstract][Full Text] [Related]
2. The diagnostic utility of anti-cyclic citrullinated peptide antibodies, matrix metalloproteinase-3, rheumatoid factor, erythrocyte sedimentation rate, and C-reactive protein in patients with erosive and non-erosive rheumatoid arthritis.
Shovman O; Gilburd B; Zandman-Goddard G; Sherer Y; Orbach H; Gerli R; Shoenfeld Y
Clin Dev Immunol; 2005 Sep; 12(3):197-202. PubMed ID: 16295525
[TBL] [Abstract][Full Text] [Related]
3. An investigation of the added value of an ACPA multiplex assay in an early rheumatoid arthritis setting.
van Heemst J; Trouw LA; Nogueira L; van Steenbergen HW; van der Helm-van Mil AH; Allaart CF; Serre G; Holmdahl R; Huizinga TW; Toes RE; van der Woude D
Arthritis Res Ther; 2015 Oct; 17():276. PubMed ID: 26437716
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.
Reyes-Castillo Z; Palafox-Sánchez CA; Parra-Rojas I; Martínez-Bonilla GE; del Toro-Arreola S; Ramírez-Dueñas MG; Ocampo-Bermudes G; Muñoz-Valle JF
Clin Exp Immunol; 2015 Nov; 182(2):119-31. PubMed ID: 26149185
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: an Italian multicentric study and review of the literature.
Bartoloni E; Alunno A; Bistoni O; Bizzaro N; Migliorini P; Morozzi G; Doria A; Mathieu A; Lotzniker M; Allegri F; Riccieri V; Alpini C; Gabrielli A; Tampoia M; Gerli R;
Autoimmun Rev; 2012 Sep; 11(11):815-20. PubMed ID: 22394488
[TBL] [Abstract][Full Text] [Related]
6. Microdevice immunoassay with conjugated magnetic nanoparticles for rapid anti-cyclic citrullinated peptide (anti-CCP) detection.
Ramos KC; Macías MDPC
Talanta; 2021 Mar; 224():121801. PubMed ID: 33379028
[TBL] [Abstract][Full Text] [Related]
7. [Cyclic citrullinated peptide antibodies (anti-CCP) together with some other parameters used for serologic diagnosis of rheumatoid arthritis].
Us D; Gülmez D; Hasçelik G
Mikrobiyol Bul; 2003; 37(2-3):163-70. PubMed ID: 14593899
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic performance of a new vimentin-derived ACPA (CCP high sensitive) in patients with rheumatoid arthritis.
Bertin D; Dubucquoi S; Lakomy D; Deleplancque AS; Desplat-Jégo S
Immunol Res; 2016 Apr; 64(2):455-60. PubMed ID: 26350265
[TBL] [Abstract][Full Text] [Related]
9. [Diagnostic and prognostic value of antibodies to cyclic citrullinated peptide (Anti-CCP) in rheumatoid arthritis].
Erre GL; Tocco A; Faedda R; Cossu A; Carcassi A
Reumatismo; 2004; 56(2):118-23. PubMed ID: 15309221
[TBL] [Abstract][Full Text] [Related]
10. Comparison of anti-CCP autoantibodies measurement by ELISA and a bead-based assay in a large patient cohort.
Harich R; Roger C; Garnier L; Bienvenu J; Fabien N
Clin Biochem; 2014 Apr; 47(6):485-8. PubMed ID: 24560656
[TBL] [Abstract][Full Text] [Related]
11. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
Greiner A; Plischke H; Kellner H; Gruber R
Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545
[TBL] [Abstract][Full Text] [Related]
12. [Diagnostic utility of AxSYM anti-cyclic Citrullinated peptide antibody assay].
Kim KE; Kim KH; Woo KS; Han JY; Kim JM; Lee SW; Chung WT
Korean J Lab Med; 2008 Dec; 28(6):457-64. PubMed ID: 19127111
[TBL] [Abstract][Full Text] [Related]
13. Clinical validation of surface-enhanced Raman scattering-based immunoassays in the early diagnosis of rheumatoid arthritis.
Chon H; Wang R; Lee S; Bang SY; Lee HS; Bae SC; Hong SH; Yoon YH; Lim DW; deMello AJ; Choo J
Anal Bioanal Chem; 2015 Nov; 407(27):8353-62. PubMed ID: 26362159
[TBL] [Abstract][Full Text] [Related]
14. Determination of serum lipoprotein lipase using a latex particle-enhanced turbidimetric immunoassay with an automated analyzer.
Machida T; Miyashita K; Sone T; Tanaka S; Nakajima K; Saito M; Stanhope K; Havel P; Sumino H; Murakami M
Clin Chim Acta; 2015 Mar; 442():130-5. PubMed ID: 25632836
[TBL] [Abstract][Full Text] [Related]
15. Technical and diagnostic performance of 6 assays for the measurement of citrullinated protein/peptide antibodies in the diagnosis of rheumatoid arthritis.
Coenen D; Verschueren P; Westhovens R; Bossuyt X
Clin Chem; 2007 Mar; 53(3):498-504. PubMed ID: 17259232
[TBL] [Abstract][Full Text] [Related]
16. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
[TBL] [Abstract][Full Text] [Related]
17. Selected cyclic citrullinated peptides derived from the sequence of mutated and citrullinated vimentin (MCV) are targeted by different antibodies subclasses in patients with rheumatoid arthritis in Russian patients.
Derganova O; Martinez-Gamboa L; Egerer K; Bang H; Fredenhagen G; Roggenbuck D; Esaulenko I; Burmester GR; Chernykh T; Feist E
Clin Exp Rheumatol; 2014; 32(5):622-9. PubMed ID: 25189876
[TBL] [Abstract][Full Text] [Related]
18. Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in leprosy patients with articular involvement.
Ribeiro SL; Pereira HL; Silva NP; Neves RM; Sato EI
Braz J Med Biol Res; 2008 Nov; 41(11):1005-10. PubMed ID: 19099154
[TBL] [Abstract][Full Text] [Related]
19. [Comparison and relevance of rheumatoid factors, antikeratin antibodies and anti-cyclic citrullinated peptides antibodies in rheumatoid arthritis].
Galati S; Beauvillain C; Renier G; Jeannin P; Masson C; Chevailler A
Ann Biol Clin (Paris); 2008; 66(2):157-64. PubMed ID: 18390426
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the frequency of antibodies to cyclic citrullinated peptides using a third generation anti-CCP assay (CCP3) in systemic sclerosis, primary biliary cirrhosis and rheumatoid arthritis.
Santiago M; Baron M; Miyachi K; Fritzler MJ; Abu-Hakima M; Leclercq S; Bell M; Hudson M; Mathieu JP; Taillefer S; Jones N; Docherty P; Khraishi M; Markland J; Pope J; Robinson D; Smith D; Sutton E
Clin Rheumatol; 2008 Jan; 27(1):77-83. PubMed ID: 17570008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
